Steering Committee

GP2 is a study led by Andrew Singleton, Ph.D., of the National Institutes of Health and an international team of scientists and researchers.

Members of the steering committee include:

Andrew B. Singleton, PhD
Biography
Lead Complex Disease

Andrew B. Singleton, PhD

National Institutes of Health | USA
Cornelis Blauwendraat, PhD
Biography
Co-Lead Complex Disease

Cornelis Blauwendraat, PhD

National Institutes of Health | USA
Alexis Brice, MD
Biography

Alexis Brice, MD

Brain and Spine Institute | France
Bradford Casey, PhD
Biography
LEAD DATA AND CODE DISSEMINATION

Bradford Casey, PhD

Michael J. Fox Foundation | USA
Brian Fiske, PhD
Biography

Brian Fiske, PhD

Michael J. Fox Foundation | USA
Tatiana Foroud, PhD
Biography
Lead Operations and Compliance

Tatiana Foroud, PhD

Indiana University | USA
Thomas Gasser, MD
Biography

Thomas Gasser, MD

University of Tubingen | Germany
John Hardy, PhD
Biography
COORDINATING LEAD PI

John Hardy, PhD

University College London | United Kingdom
Peter Heutink, PhD
Biography
Lead Monogenic Data Analysis

Peter Heutink, PhD

German Center for Neurodegenerative Diseases | Germany
Rejko Kruger, MD
Biography

Rejko Kruger, MD

University of Luxembourg | Luxembourg
Ken Marek, MD
Biography

Ken Marek, MD

Michael J. Fox Foundation | USA
Ignacio Fernandez Mata, PhD
Biography
Lead Underrepresented Populations

Ignacio Fernandez Mata, PhD

Cleveland Clinic | USA
Huw Morris, FRCP, PhD
Biography
Lead Complex Disease Cohort Integration

Huw Morris, FRCP, PhD

University College London | United Kingdom
Michael Nalls, PhD
Biography
Lead Complex Disease Data Analysis

Michael Nalls, PhD

Data Tecnica International | USA
Alastair Noyce, MRCP, PhD
Biography
Lead Training, Networking, and Communication

Alastair Noyce, MRCP, PhD

Queen Mary University of London | United Kingdom
Alyssa Reimer, BA
Biography
Co-Lead Operations and Compliance

Alyssa Reimer, BA

Michael J. Fox Foundation | USA
Ekemini A. U. Riley, PhD
Biography
Managing Director

Ekemini A. U. Riley, PhD

Aligning Science Across Parkinson's (ASAP) | USA
Justin C. Solle, MBA
Biography

Justin C. Solle, MBA

Michael J. Fox Foundation | USA
Enza Maria Valente, MD, PhD
Biography
Lead Monogenic Portal

Enza Maria Valente, MD, PhD

University of Pavia | Italy
Nigel Williams, PhD
Biography

Nigel Williams, PhD

Cardiff University | United Kingdom
Nicholas Wood, PhD
Biography
COORDINATING LEAD PI

Nicholas Wood, PhD

University College London | United Kingdom

GP2 Friends

La misión de la Michael J. Fox Foundation consiste en encontrar una cura para la enfermedad de Parkinson a través de un agresivo programa de investigación con financiación sólida y promover tratamientos mejorados para los pacientes actuales de enfermedad de Parkinson.

The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson’s today.

La Fondation Michael J. Fox s’emploie à trouver une cure à la maladie de Parkinson grâce à un programme agressif de financement de la recherche et à l’amélioration des thérapies de ceux qui souffrent aujourd’hui de la maladie.

Die Michael J. Fox Foundation setzt sich mit Hilfe einer offensiv finanzierten Forschungsagenda dafür ein, eine Heilungsmethode für die Parkinson-Krankheit zu finden und für die Entwicklung verbesserter Therapien für die Menschen zu sorgen, die heute mit Parkinson leben.

تكرس مؤسسة مايكل ج. فوكس جهودها لإيجاد علاج لداء باركنسون، وذلك من خلال تنفيذ أجندة بحثية مموّلة بسخاء، بالإضافة إلى ضمان تطوير مقاربات علاجية مُحسّنة تستهدف الأشخاص الذين يتعايشون مع المرض اليوم.

マイケル・J・フォックス財団は、研究に巨額の資金を投入し、今パーキンソン病を患っている人たちへの治療薬の開発を支援することで、パーキンソン病治療へ注力しています。

迈克尔-J-福克斯基金会大力支持帕金森病研究,保证研究经费充足,以期根治帕金森病,同时亦致力于为当下的帕金森病患者开发出更好的疗法。

Repositorio de información y enlaces relacionados con el trabajo del International Parkinson’s Disease Genomics Consortium.

A repository of information and links related to the work of the International Parkinson’s Disease Genomics Consortium.

Eine Sammlung von Informationen und Links rund um die Arbeit des International Parkinson’s Disease Genomics Consortium.

مستودع للمعلومات والروابط المتعلقة بعمل الائتلاف الدولي لدراسة جينومات داء باركنسون.

国际帕金森病基因组学联盟(IPDGC)工作的相关信息和链接库。

国際パーキンソン病ゲノミクスコンソーシアムの研究に関わる情報とリンクのレポジトリ

PD GENEration: Mapping the Future of Parkinson’s Disease, is a first-of-its-kind national initiative that offers free genetic testing for clinically relevant Parkinson’s-related genes and free genetic counseling to help participants better understand their results.

GENEration MP : Mapping the Future of Parkinson’s Disease (cartographier l’avenir de la maladie de Parkinson), est une initiative nationale unique en son genre qui offre un dépistage génétique gratuit des gènes apparentés à la maladie de Parkinson et des conseils génétiques gratuits pour aider les participants à mieux comprendre leurs résultats.

PD GENEration: ‘Mapping the Future of Parkinson’s Disease’ ist die erste nationale Initiative, die kostenlose Gentests auf klinisch relevante Parkinson-Gene und kostenlose genetische Beratung anbietet. Ziel ist es, den Teilnehmenden zu helfen, ihre Befunde besser zu verstehen.

PD GENEration: ترسيم مستقبل داء باركنسون، هي المبادرة الوطنية الأولى من نوعها التي توفر فحصا جينيا مجانيا للجينات ذات الصلة المرتبطة بداء باركنسون واستشارة جينية مجانية لمساعدة المشاركين على فهم نتائجهم بشكل أفضل.

PD GENEration: Mapping the Future of Parkinson’s Disease (GENeración EP: cartografía del futuro de la enfermedad de Parkinson), es una iniciativa estadounidense de alcance nacional que ofrece pruebas genéticas gratuitas de genes relacionados con la enfermedad de Parkinson clínicamente relevantes y asesoría genética gratuita para ayudar a los participantes a comprender mejor sus resultados.

PD GENEration:绘制帕金森病的未来图谱是一项全国首创的倡议,免费检测临床相关的帕金森相关基因,并提供免费的遗传咨询,以帮助参与者更好地了解检测结果。

PD GENEration:パーキンソン病の未来のマッピングは、全国初のイニシアチブとして、臨床的に関連性のあるパーキンソン病関連遺伝子の遺伝子テスト、そして患者が結果を理解できるように遺伝子カウンセリングを無料で提供します。

Collaboration de plusieurs centres sur le continent africain unissant leurs efforts pour faire avancer les connaissances sur la maladie de Parkinson et sa génétique dans la région.

Colaboración con múltiples centros de África, con el objetivo de profundizar el conocimiento acerca de la enfermedad de Parkinson y la genética de dicha enfermedad en la región.

A multicenter collaboration across Africa in an effort to increase the knowledge about PD and PD genetics in the region.

Eine Kooperation mehrerer afrikanischer Zentren mit dem Ziel, das Wissen über die Parkinson-Krankheit und die Parkinson-Genetik in der Region auszubauen.

يهدف هذا التعاون القائم بين مراكز متعددة في مختلف أنحاء أفريقيا إلى زيادة المعرفة حول داء باركنسون والجينات المرتبطة به في المنطقة.

IPDGC非洲分部是横跨非洲的多中心合作,旨在促进非洲地区的帕金森病和帕金森病遗传学研究。

地域のPDとPD遺伝学の知見を深めるアフリカの複数センターのコラボレーション

Colaboración con múltiples centros de América Latina, con el objetivo de profundizar el conocimiento acerca de la enfermedad de Parkinson y la genética de dicha enfermedad en la región.

地域のPDとPD遺伝学の知見を深めるラテンアメリカの複数センターのコラボレーション

A multicenter collaboration across Latin America in an effort to increase the knowledge about PD and PD genetics in the region.

Eine Kooperation mehrerer lateinamerikanischer Zentren mit dem Ziel, das Wissen über die Parkinson-Krankheit und die Parkinson-Genetik in der Region auszubauen.

يهدف هذا التعاون القائم بين مراكز متعددة في مختلف أنحاء أميركا اللاتينية إلى زيادة المعرفة حول داء باركنسون والجينات المرتبطة به في المنطقة.

Collaboration de plusieurs centres d’un bout à l’autre de l’Amérique latine, unissant leurs efforts pour faire avancer les connaissances sur la maladie de Parkinson et sa génétique dans la région.

LARGE-PD是横跨拉丁美洲的多中心合作,旨在促进该地区的帕金森病和帕金森病遗传学研究。

Collaboration de plusieurs centres de toute l’Asie du Sud-Est unissant leurs efforts pour faire avancer les connaissances sur la maladie de Parkinson et sa génétique dans la région.

Colaboración con múltiples centros de Asia Oriental, con el objetivo de profundizar el conocimiento acerca de la enfermedad de Parkinson y la genética de dicha enfermedad en la región.

A multicenter collaboration across East Asia in an effort to increase the knowledge about PD and PD genetics in the region.

Eine Kooperation mehrerer Zentren in Ostasien mit dem Ziel, das Wissen über die Parkinson-Krankheit und die Parkinson-Genetik in der Region auszubauen.

يهدف هذا التعاون القائم بين مراكز متعددة في مختلف أنحاء شرق أسيا إلى زيادة المعرفة حول داء باركنسون والجينات المرتبطة به في المنطقة.

IPDGC是横跨东亚的多中心合作,旨在促进东亚地区的帕金森病和帕金森病遗传学研究。

L’Architecture génétique de la maladie de Parkinson dans la population indienne (GAP-India) est une collaboration établie entre plusieurs centres pour élargir les connaissances sur la maladie de Parkinson en Inde.

The Genetic Architecture of Parkinson’s Disease in the Indian Population (GAP-India) ist eine mehrere Zentren umfassende Kooperation zur Verbesserung des Wissensstandes über die Parkinson-Krankheit in Indien.

La iniciativa Arquitectura genética de la enfermedad de Parkinson en la población india (GAP-India) es una colaboración entre múltiples centros que tiene por objeto profundizar el conocimiento sobre la EP en India.

The Genetic Architecture of Parkinson’s disease in the Indian population (GAP-India) is a multicenter collaboration to increase knowledge about PD in India.

البنية الجينية لداء باركنسون في سكان الهند (GAP-INDIA) هو تعاون بين عدة مراكز لزيادة المعرفة حول داء باركنسون في الهند.

インド人(GAP-インド) のパーキンソン病の遺伝子構造は、インドのPDの知見を深める複数拠点の協働です。

印度人口中帕金森病的遗传结构(GAP-India)是一个多中心合作项目,旨在增加对印度帕金森病的了解。

Depuis sa création en 2004, le Consortium sur l’epidémiologie génétique de la maladie de Parkinson (GEoPD) regroupe dans le monde entier des chercheurs engagés dans la pormotion de l’éducation, la recherche scientifique et le développement translationnel dans la maladie de Parkinson.

Genetic Epidemiology of Parkinson’s disease (GEoPD) コンソーシアムは2004年に創設され、PDの啓蒙、科学研究、翻訳開発の推進を行う研究者によるグローバルなコンソーシアムです。

Das Genetic Epidemiology of Parkinson’s Disease (GEoPD) Consortium ist ein weltweiter Forschungsverbund, der sich seit seiner Gründung im Jahr 2004 der Förderung von Bildung, wissenschaftlicher Forschung und translationaler Entwicklung im Bereich Parkinson verschrieben hat.

El Consorcio de epidemiología genética de la enfermedad de Parkinson (GEoPD), fundado en el 2004, es un consorcio a escala mundial de investigadores dedicados a promocionar la educación, la investigación científica y el desarrollo traslacional en la EP.

帕金森氏病的遗传流行病学(GEoPD)联盟是一个全球性的研究者联盟,自2004年成立以来,该联盟一直致力于促进帕金森病的教育、科学研究和转化发展。

The Genetic Epidemiology of Parkinson’s disease (GEoPD) Consortium is a global consortium of researchers dedicated to promoting education, scientific research, and translational development in PD since its establishment in 2004.

الائتلاف الدولي لدراسة الأوبئة الجينية لداء باركنسون (GEOPD) هو ائتلاف دولي من الباحثين كرس عمله منذ تأسيسه عام 2004 لتعزيز التعليم، البحث العلمي، والتطورات الانتقالية لداء باركنسون.

地域のPDとPD遺伝学の知見を深める東アジアの複数センターのコラボレーション

Un recueil d’informations et de liens relatifs aux travaux menés par le Consortium international de génomique sur la maladie de Parkinson

Working Group Members

Andrew B. Singleton, PhD

National Institutes of Health | USA

Member of:
Complex Disease Network

Cornelis Blauwendraat, PhD

National Institutes of Health | USA

Member of:
Complex Disease Network
Complex Disease – Data Analysis

Caroline Pantazis, PhD

National Institutes of Health | USA

Member of:
Complex Disease Network

Ruqaya Murtadha

National Institutes of Health | USA

Members of:
Complex Disease Network

Christine Klein, MD, FEAN

University of Luebeck | Germany

Member of:
Monogenic Hub
Monogenic – Sample Prioritization

Katja Lohmann, PhD

University of Luebeck | Germany

Member of:
Monogenic Hub

Niccolo Mencacci, MD, PhD

Northwestern University | USA

Member of:
Monogenic Hub

Kishore Raj Kumar, MBBS, PhD, FRACP

University of Sydney | Australia

Member of:
Monogenic Hub
Monogenic – Sample Prioritization

Peter Heutink, PhD

German Center for Neurodegenerative Diseases | Germany

Member of:
Monogenic Hub
Monogenic – Data Analysis
Underrepresented Populations

Shen-Yang Lim, MBBS, MD, FRACP, FASc

Univeristy of Malaya | Malaysia

Member of:
Monogenic Hub
Underrepresented Populations

Lara Lange, MD

University of Luebeck | Germany

Member of:
Monogenic Hub

Enza Maria Valente, MD, PhD

University of Pavia | Italy

Member of:
Monogenic Hub
Monogenic – Portal Development

Micol Avenali, MD

University of Pavia | Italy

Member of:
Monogenic Hub

Eva-Juliane Vollstedt, MD

University of Luebeck | Germany

Member of:
Monogenic Hub
Monogenic – Sample Prioritization

Ignacio Juan Keller Sarmiento, MD

Northwestern University | USA

Member of:
Monogenic Hub

Anastasia Illarionova

German Center for Neurodegenerative Diseases | Germany

Member of:
Monogenic Hub

Ai Huey Tan, MD, FRCP

University of Malaya | Malaysia

Member of:
Monogenic Hub

Zih-Hua Fang, PhD

German Center for Neurodegenerative Diseases | Germany

Member of:
Monogenic Hub
Monogenic – Data Analysis

Julie Hunter, BSc

ANZAC Research Institute | Australia

Member of:
Monogenic Hub
Monogenic – Sample Prioritization

Huw Morris, FRCP, PhD

University College London | UK

Member of:
Complex Disease – Cohort Integration

Hirotaka Iwaki, MD, PhD

Data Technica International / National Institutes of Health | USA

Member of:
Complex Disease – Cohort Integration
Complex Disease – Data Analysis
Underrepresented Populations

Manuela Tan, BSc

University College London  | UK

Member of:
Complex Disease – Cohort Integration

Alejandro Martinez Carrasco, MSc

University College London | UK

Member of:
Complex Disease – Cohort Integration
Training, Networking and Communication

Mike A. Nalls, PhD

Data Tecnica International | USA

Member of:
Complex Disease – Data Analysis

Hampton Leonard, MS

Data Tecnica International / National Institutes of Health | USA

Member of:
Complex Disease – Data Analysis
Training, Networking, and Communication

Sara Bandres-Ciga, PharmD, PhD

National Institutes of Health | USA

Member of:
Complex Disease – Data Analysis
Underrepresented Populations
Training, Networking, and Communication

Jean-Christophe Corvol, MD, PhD

ICM Institute | France

Member of:
Complex Disease – Data Analysis

Ignacio Fernandez Mata, PhD

Cleveland Clinic | USA

Member of:
Complex Disease – Data Analysis
Underrepresented Populations

Jeff J. Kim, BA

National Institutes of Health | USA

Member of:
Complex Disease – Data Analysis
Data and Code Dissemination

Mary B. Makarious, BSc

National Institutes of Health | USA

Member of:
Complex Disease – Data Analysis

Yeajin Song, MS

Data Tecnica International | USA

Member of:
Complex Disease – Data Analysis

Dan Vitale, MS

Data Tecnica International | USA

Member of:
Complex Disease – Data Analysis

Nigel Williams, PhD

Cardiff University | UK

Member of:
Complex Disease – Data Analysis

Faraz Faghri, PhD

Data Tecnica International / National Institutes of Health | USA

Member of:
Complex Disease – Data Analysis

Bradford Casey, PhD

Michael J. Fox Foundation | USA

Member of:
Data and Code Dissemination

Mary B. Makarious, BSc

National Institutes of Health | USA

Member of:
Data and Code Dissemination

Artur Francisco Schumacher Schuh, MD, PhD

Latin America Universidade Federal do Rio Grande do Sul | Brazil

Member of:
Underrepresented Populations

Olaitan Okunoye, MSc,

Africa University College London | UK

Member of:
Underrepresented Populations

 

Rejko Kruger, MD

Luxembourg Centre for Systems Biomedicine | Luxembourg

Member of:
Underrepresented Populations

Kin Mok, MBBS, FRCP(E), PhD

University College London | UK

Member of:
Underrepresented Populations

Alastair Noyce, MRCP, PhD

Queen Mary University of London | UK

Member of:
Underrepresented Populations
Training, Networking, and Communication

Njideka Okubadejo, MBChB, FMCP

University of Lagos | Nigeria

Member of:
Underrepresented Populations

Mie Rizig, MD, PhD

University College London | UK

Member of:
Underrepresented Populations

Manu Sharma, PhD

University of Tubingen | Germany

Member of:
Underrepresented Populations

Joshua Shulman. MD, PhD

Baylor College of Medicine | USA

Member of:
Underrepresented Populations

Bernadette Siddiqi

Michael J. Fox Foundation | USA

Member of:
Underrepresented Populations

Soraya Bardien, PhD
Stellenbosch University  | South Africa

Member of:
Underrepresented Populations

Alyssa Reimer, BA

Michael J. Fox Foundation | USA

Member of:
Operations and Compliance

Tatiana Foroud, PhD

Indiana University | USA

Member of:
Operations and Compliance

Alyssa Reimer, BA

Michael J. Fox Foundation | USA

Member of:
Operations and Compliance

Maggie Kuhl

Michael J. Fox Foundation | USA

Member of:
Operations and Compliance

Claire Wegel, MPH

Indiana University School of Medicine | USA

Member of:
Operations and Compliance

Patrick Lewis, PhD

Royal Veterinary College | UK

Member of:
Training, Networking, and Communication

Benjamin Stecher

Patient advocate and author | Canada

Member of:
Training, Networking, and Communication

Simon Stott

Cure Parkinson’s Trust | UK

Member of:
Training, Networking, and Communication

Claire Bale, MSc
Parkinson’s UK | UK

Member of:
Training, Networking, and Communication

 

Sabina Adams

Queen Mary University of London | UK

Member of:
Training, Networking, and Communication

Sumit Dey, MSc

Queen Mary University of London | UK 

Member of:
Training, Networking, and Communication